Moderately to Severely Active Ulcerative Colitis trials recruiting in Alabama

Fewer than 3 recruiting trials found.

All Moderately to Severely Active Ulcerative Colitis trials nationally

Cities in Alabama

Recruiting trials in Alabama

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT06588855 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Alabama: Dothan